Details for 2012835407
Up to date per 22.04.2026
Actions
Details for 2012835407
Granted/Registered
European Patent
06.08.2014 A
03.05.2017 B1
30.09.2011
US
201161542100 P
29.11.2011
US
201161564668 P
G01N 33/49 20060101AFI20160630BHEP
Owner
Immedica Pharma ABNorrtullsgatan 15113 29 StockholmSE
Representative
Representative
Haffner & Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
SCHARSCHMIDT, Bruce45 St. Francis Boulevard San Francisco California 94127US
MOKHTARANI, Masoud725 Castle Rock Road Walnut Creek California 94598US
Information about Fees